Treatment-resistant depression (TRD) is a condition where depressive symptoms continue even after trials with at least two different oral antidepressants. Spravato is an esketamine nasal spray, administered in a certified clinical setting under the supervision of a healthcare provider. Here’s more information on esketamine spray for TRD, and what the long-term effects are:
Esketamine and Depression Symptoms
Esketamine is a prescription medication derived from ketamine, a well-known anesthetic that has been used in medical settings for decades. Classified as an NMDA receptor antagonist, esketamine works uniquely compared to traditional antidepressants by modulating glutamate, a key neurotransmitter involved in brain function. Due to this interaction, esketamine can rapidly address treatment-resistant depression, often providing relief within hours or days.
The Administering Process
When administered, Spravato is observed to impact symptoms of depression, but patient responses can vary. Clinicians monitor individuals closely during and after each treatment session for changes in mood, thought patterns, and potential side effects. This careful observation is a standard part of the treatment protocol for safety and to track the medication’s influence on depressive symptoms over time.
Some common symptoms that treatment-resistant depression may cause are:
- Persistent feelings of sadness or hopelessness
- Loss of interest or pleasure in activities once enjoyed
- Difficulty concentrating or making decisions
- Fatigue or lack of energy, even with sufficient rest
- Sleep disturbances, including insomnia or excessive sleep
- Recurrent thoughts of death or suicidal ideation
The Neurotransmitter Impacts
Traditional antidepressants work by increasing levels of key neurotransmitters like serotonin, norepinephrine, and dopamine, which are fundamental in communication between brain cells. These chemicals often become imbalanced in individuals with depression, and their regulation can improve mood and reduce depressive symptoms over time. Spravato operates on a similar foundational theory but achieves results through a different mechanism. It targets glutamate, the brain’s most abundant neurotransmitter, to stimulate a broader network of brain cells simultaneously. This rapid impact on brain communication pathways represents a significant advancement in depression treatment.
Esketamine and Short-term Benefits
During the initial phases of treatment, some individuals using esketamine nasal sprays have reported a range of short-term benefits. Some observed or reported short-term benefits may include:
- Faster onset of mood improvement,
- Reduction in anhedonia (which is the inability to feel pleasure),
- Improved cognitive flexibility and function.
- Greater engagement in concurrent psychotherapies and other supportive care.
Esketamine and Long-term Benefits
The discussion around the long-term effects of Spravato involves an evaluation of sustained response and remission. For patients who show improvement, treatment often transitions to a maintenance phase with less frequent dosing schedules. The goal of this phase is to maintain the initial benefits, and adherence to the prescribed schedule is a key factor in achieving this. The durability of Spravato’s effects is an ongoing area of study. Some research suggests that continued treatment can help delay the return of depressive symptoms for individuals who have responded to the initial therapy.
Upon discontinuation of esketamine, no trends were observed to suggest that long-term use of the treatment is associated with withdrawal. Even after a year of use, esketamine sprays have been shown to improve symptoms and daily functioning. Concurrent treatments, like psychotherapy and ongoing use of an oral antidepressant, are integral parts of the overall care plan and may contribute to long-term stability.
Learn More About Spravato
Making an informed decision about any medical treatment requires planning and professional guidance. To learn more about Spravato, including its potential benefits and risks, schedule a consultation with a qualified provider. By working with a healthcare team with comprehensive monitoring, you can find a solution to your depressive symptoms. Contact a psychiatrist today for more information on esketamine and its uses.
